位置:成果数据库 > 期刊 > 期刊详情页
肿瘤干细胞在妇科肿瘤中的研究进展
  • 期刊名称:国际妇产科学杂志
  • 时间:0
  • 页码:112-114
  • 语言:中文
  • 分类:R737.33[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]中山大学孙逸仙纪念医院妇科,广州510000
  • 相关基金:国家自然科学基金资助项目(No:30872743/C1701);国家自然科学基金青年科学基金资助项目(No:81101979);广州市科技项目(No:2010J-E291)
  • 相关项目:干预ALDH-1调控宫颈癌干细胞特性的研究
中文摘要:

目的:研究放疗诱导后的耐放疗宫颈癌 Hela、Siha 细胞系顺铂耐药情况及经典 Wnt 通路相关分子在其化疗耐受中的作用。方法:分割剂量多次照射诱导宫颈癌细胞并成功建立耐放疗细胞系,将细胞分为 R0组(空白对照)、R1组(分割剂量4GY,照射6次)和 R2组(分割剂量6GY,照射4次)。 CCK8法进行耐药实验,Real-time PCR 及 West-ern blot 法检测 Wnt/β-catenin 通路及耐药分子表达情况。结果:Hela R0、R1、R2顺铂 IC50分别为3.86、6.65μmol/ L 和6.53μmol/ L,Siha R0、Siha R1、Siha R2顺铂 IC50分别为4.79、7.25μmol/ L 和7.98μmol/ L;与 R0组相比,其他两组的 IC50显著升高,差异有统计学意义(P〈0.001)。放疗诱导宫颈癌 Hela、Siha 细胞中经典 Wnt 通路分子在基因与蛋白水平受到激活,其下游基因 C-Myc、Cyclin D1表达增多,放疗诱导 Hela 细胞中耐药蛋白 ABCB1、ABCG2表达升高,而放疗诱导 Siha 细胞中上述耐药蛋白变化无统计学差异。结论:经典Wnt 通路可能是放疗诱导宫颈癌细胞化疗耐受性获得的重要机制,这为复发性宫颈癌患者提供了潜在治疗靶点。

英文摘要:

Objective:To investigate the expression of the main molecules in Wnt ca-nonical pathway and cis-platinum resistance in radiation induced cervical cancer cell lines Hela and Siha. Methods:Fractional dose radiotherapy was used to establish radio-resistant cell lines. Real-time PCR and Western Blot assays were employed to test the expressions of the Wnt path-way main members and chemoresistant related protein-ABCB1 and ABCG2. CCK8 assay was used to detect cell viability after cisplatine treatment. Results:The IC50 of R0,R1 and R2 were 3. 86,6. 65,6. 53μmol/ L in Hela,respectively,and 4. 79,7. 25,7. 98μmol/ L in Siha,respec-tively. Compared to R0,IC50 in R1 and R2 were significantly increased(P〈0. 001). The Wnt canonical pathway proteins such as Wnt1,β-catenin,C-Myc,Cyclin D1 were activated in the ra-dio-resistant cell lines at both mRNA and protein levels,the chemoresistant related protein AB-CB1 and ABCG2 were activated in radio-induced Hela cells only. Conclusions:The activation of Wnt canonical pathway could be a significant molecular mechanism of cis-platinum resistance in radiation induced cervical cancers. It may provide a potential target of treatment for recurrent cervical cancer.

关于姚婷婷:

关于林仲秋:

同期刊论文项目
同项目期刊论文